Skip to main content

Illumina, Inc. (ILMN)

NASDAQ: ILMN · IEX Real-Time Price · USD
450.00
+2.99 (0.67%)
After-hours:Sep 17, 2021 7:59 PM EDT
447.01
-2.91 (-0.65%)
At close: Sep 17, 4:00 PM

Company Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.

Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements.

Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa.

It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency.

The company was incorporated in 1998 and is headquartered in San Diego, California.

Illumina, Inc.
Illumina Logo
CountryUnited States
Founded1998
IPO DateJul 28, 2000
IndustryLife Sciences Tools & Services
SectorHealth Care
Employees7,800
CEOFrancis deSouza

Contact Details

Address:
5200 Illumina Way
San Diego, California 92122-4616
United States
Phone858 202 4500
Websiteillumina.com

Stock Details

Ticker SymbolILMN
ExchangeNASDAQ
Fiscal YearFebruary - January
Reporting CurrencyUS Dollars
CIK Code0001110803
CUSIP Number452327109
ISIN NumberUS4523271090
Employer ID33-0804655

Key Executives

NamePosition
Francis A. deSouzaChief Executive Officer and Director
Sam A. SamadChief Financial Officer
Dr. Alexander Aravanis M.D., Ph.D.Chief Technology Officer and Head of Research and Product Development
Susan H. TousiChief Commercial Officer
Stephanie CamposPresident
Robert P. RagusaChief Operations Officer
Jose A. Torres Jr.Chief Accounting Officer and Vice President
Steve PhillpottSenior Vice President and Chief Information Officer
Charles E. DadswellSenior Vice President, General Counsel and Secretary
Eric EndicottSenior Director of Corporate Communications